Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock are in focus as the firm are cutting the prices of their popular GLP-1 ...

Eli Lilly also undertook 2-for-1 stock splits in 1995, 1989 and 1986. The company has been publicly traded since 1952. Despite its rapid growth in recent years, fueled by its popular weight-loss drugs ...

Eli Lilly LLY and Novo Nordisk NVO, long-standing rivals and the two dominant forces in the GLP-1 obesity market, are now locked in an intensified battle as both companies slash prices to defend and ...

Eli Lilly and Company’s LLY stock has been consistently trading above its 50-day and 200-day simple moving averages (SMAs) since early October. The 50-day moving average is a short-term indicator, ...

Eli Lilly (LLY) has shown considerable rally potential, with several occurrences of its stock climbing over 30% in less than ...

Eli Lilly and Company (NYSE:LLY) is one of the best growth stocks to buy in 2026. On December 15, Bank of America analyst Jason Gerberry lowered the firm’s price target on Eli Lilly to $1,268 from $1, ...

The latest trading day saw Eli Lilly (LLY) settling at $1, representing a +1.45% change from its previous close.

In this photo illustration, a Eli Lilly logo seen displayed on a smartphone. Eli Lilly’s stock (NYSE: LLY) has recently surged 27% over the past month, reaching a current price of $1,022. This rally ...

Insiders from Eli Lilly disclosed multiple purchases in August, which piqued my interests for several reasons. After more digging, I do not consider their purchase prices (or the stock’s current ...